Annual report pursuant to Section 13 and 15(d)

Schedule of Segment Information (Details)

v3.10.0.1
Schedule of Segment Information (Details) - USD ($)
$ in Thousands
12 Months Ended
Nov. 30, 2018
Nov. 30, 2017
Revenues $ 18,655 $ 10,089
Cost of revenues (10,824) (6,807)
Gross profit (loss) 7,831 3,282
Research and development expenses, net (6,464) (2,478)
Operating profit (loss) (14,650) (11,230)
Depreciation and amortization expense (2,624) (2,598)
Segment Performance 12,743 8,149
CDMO [Member]    
Revenues 22,582 11,484
Cost of revenues (11,541) (6,356)
Gross profit (loss) 11,041 5,128
Research and development expenses, net (39)  
Operating expenses (6,889) (4,699)
Other expenses (77)  
Operating profit (loss) 4,036 429
Depreciation and amortization expense (2,613) (2,720)
Segment Performance 1,423 (2,291)
CTB [Member]    
Revenues 0 0
Gross profit (loss) 0 0
Research and development expenses, net (7,931) (2,517)
Operating expenses (6,224) (3,335)
Other expenses 0  
Operating profit (loss) (14,155) (5,852)
Depreciation and amortization expense (11) (6)
Segment Performance (14,166) (5,858)
Corporate and Eliminations [Member]    
Revenues (3,927) (1,395)
Cost of revenues 1,235 638
Gross profit (loss) (2,692) (757)
Research and development expenses, net 2,485 757
Operating expenses 207  
Operating profit (loss) 0 0
Consolidated [Member]    
Revenues 18,655 10,089
Cost of revenues (10,306) (5,718)
Gross profit (loss) 8,349 4,371
Research and development expenses, net (5,485) (1,760)
Operating expenses (12,906) (8,034)
Other expenses (77)  
Operating profit (loss) (10,119) $ (5,423)
Depreciation and amortization expense (2,624)  
Segment Performance $ (12,743)